Abstract:Objective To investigate the changes of serum adiponectin and visfatin/pre-B cell colony-enhan cing factor(PBEF)levels in patients with metabolic syndrome(MS),so as to understand their association with MS.Methods According to the diagnostic criteria for MS recommended by the Chinese Medical Association in 2004,42 patients with MS were selected for this study with 30 healthy subjects as the control group.After mea- surement of the height,body weight and waist circumference,fasting blood samples were collected from all partici- pants to determine the fasting plasma glucose(FPG),serum insulin,adiponectin and visfatin levels.Radioimmuno- assay(RIA)was employed for serum adiponectin level measurement;enzyme-linked immunoassay(EIA)was used for visfatin detection;and homeostasis model assessment of insulin resistance(HOMA-IR)was calculated based on FPG and insulin measurements.Results①There were 22 males and 20 females in the MS group,with a mean age of(53±10)years old;there were 18 males and 12 females in the control group,with a mean age of(49±10) years.The ages and sex structure were matchable between the two groups(both P>0.05).②Serum visfatin levels was significantly higher in the MS patients than in the control subjects([97.57±40.69]μg/L vs [50.54±19.14]μg/L,P<0.05),but the adiponectin level was significantly lower([7.98±3.62] mg/L vs [13.55±5.72] mg/L,P<0.01).③In patients with MS,serum visfatin level was positively correlated with the waist circumference(Satandard partial regression cofficient=0.415,P=0.000),but not with other metabolic indices such as adiponectin,serum insulin,body mass index,HOMA-IR,or triglycerol;adiponectin level was positively correlated with high-density lipoprotein cholesterol(HDL-C)level(Satandard partial regression cofficient=0.312, P=0.004)but inversely with HOMA-IR(Satandard partial regression cofficient=-0.341,P=0.002)and the waist-hip ratio(Satandard partial regression cofficient=-0.211,P=0.048).Conclusions Significantly elevated visfatin and decreased adiponeetin levels occur in MS patients.Visfatin may play a role in the development of viscer al obesity,and adiponectin may inhibit insulin resistance and dyslipidiemia.No obvious correlation between visfatin and adiponectin is suggested.

Association of Plasma Concentration of Visfatin with Obesity and Metabolic Parameters in Chinese Han Adults

Positive Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population.

Correlations of Serum Visfatin and Metabolisms of Glucose and Lipid in Women with Gestational Diabetes Mellitus

Association of Visfatin with Age and High-Density Lipoprotein-Cholesterol in Obese Adolescents

Expression of Visfatin and Its Related Factors in Obese Subject of Uygur.

A Research on Correlation between Serum Visfatin and Glucose and Lipid Metabolism among Women with Gestational Diabetes Mellitus

Serum Visfatin Concentrations in Obese Adolescents and Its Correlation with Age and High-Density Lipoprotein Cholesterol

The Visfatin Gene is Associated with Glucose and Lipid Metabolism in a Chinese Population.

Correlation of Plasma Visfatin with Type 2 Diabetes Mellitus

Study on the relationship between plasma visfatin levels and newly diagnosed patients with type 2 diabetes of Han autonomous in Henan

Plasma visfatin level in obese patients of nondiabetic first-degree relatives of type 2 diabetes

Relationship Between Serum Visfatin Level and Children and Adolescent Obesity and Non-Alcoholic Fatty Liver Disease

Correlation of serum visfatin and adiponectin levels with metabolic syndrome

Plasma Visfatin Levels in Patients with Newly Diagnosed and Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

Visfatin and Adiponectin Levels in Metabolic Syndrome Patients and Their Influencing Factors

Truncal and Leg Fat Associations with Metabolic Risk Factors among Chinese Adults.

Correlation between visfatin and Lp-PLA2 in patients with different typed hyperlipidemia

Relationship among serum leptin, free fatty acid and adiponectin levels in obesity

Association of Visfatin with Blood Glucose, Insulin Resistance and Body Mass Index in Patients with Type 2 Diabetes/Pre-Diabetes

[Association Between Serum Leptin, Adiponectin, Visfatin, Obesity and Hypertension in Female].

The change of plasma visfatin level in women with polycystic ovary syndrome